Lepu Medical Technology (Beijing) Co Ltd (300003):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Lepu Medical Technology (Beijing) Co Ltd (300003) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3415
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Lepu Medical Technology (Beijing) Co Ltd (Lepu Medical) is a medical technology company that offers medical equipments, pharmaceutical products and healthcare services. The company’s products include cardiovascular interventional products, surgical cardiology products, peripheral interventional products, structural heart diseases products, cardiac rhythm management products, critical care products, digital subtraction angiography systems, in vitro diagnostic products, dialysis products and general surgery products. It offers pharmaceutical products such as cardiovascular system drugs, central nervous system drugs, digestive system drugs, respiratory system drugs, nutrition, antimicrobial drugs and traditional Chinese medicine. The company healthcare services including precision medicine, ECG telemonitoring, cardiovascular disease consultation and management center and others. It operates through its production facility located in China. Lepu Medical is headquartered in Beijing, China.

Lepu Medical Technology (Beijing) Co Ltd (300003) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Lepu Medical Technology (Beijing) Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Lepu Medical Technology (Beijing) Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Lepu Medical Technology (Beijing) Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Lepu Medical Technology (Beijing) Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Lepu Medical Technology (Beijing) Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Lepu Medical Technology (Beijing) Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Lepu Medical Technology (Beijing) Co Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Equity Offering 11
Viralytics Raises USD21.6 Million in Private Placement of Shares 11
Shanghai Junshi Bioscience to Raise Funds through Private Placement of Shares 13
Lepu Medical Technology Raises USD208.4 Million in Private Placement of Shares 14
Debt Offering 15
Lepu Medical Tech Plans to Raise upto USD165.8 Million in Public Offering of Bonds 15
Lepu Medical Technology Plans to Raise USD187.1 Million in Private Placement of Notes 16
Acquisition 17
Lepu Medical to Acquire 45% Equity Stake in Zhejiang Xindonggang Pharma for USD165.8 Million 17
Lepu Medical Technology to Acquire Henan-Based Pharma Company for USD8 Million 18
Lepu Medical Technology (Beijing) Co Ltd – Key Competitors 19
Lepu Medical Technology (Beijing) Co Ltd – Key Employees 20
Lepu Medical Technology (Beijing) Co Ltd – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Lepu Medical Technology (Beijing) Co Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Lepu Medical Technology (Beijing) Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Lepu Medical Technology (Beijing) Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Lepu Medical Technology (Beijing) Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Lepu Medical Technology (Beijing) Co Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Lepu Medical Technology (Beijing) Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Lepu Medical Technology (Beijing) Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Viralytics Raises USD21.6 Million in Private Placement of Shares 11
Shanghai Junshi Bioscience to Raise Funds through Private Placement of Shares 13
Lepu Medical Technology Raises USD208.4 Million in Private Placement of Shares 14
Lepu Medical Tech Plans to Raise upto USD165.8 Million in Public Offering of Bonds 15
Lepu Medical Technology Plans to Raise USD187.1 Million in Private Placement of Notes 16
Lepu Medical to Acquire 45% Equity Stake in Zhejiang Xindonggang Pharma for USD165.8 Million 17
Lepu Medical Technology to Acquire Henan-Based Pharma Company for USD8 Million 18
Lepu Medical Technology (Beijing) Co Ltd, Key Competitors 19
Lepu Medical Technology (Beijing) Co Ltd, Key Employees 20
Lepu Medical Technology (Beijing) Co Ltd, Subsidiaries 21

List of Figures
Lepu Medical Technology (Beijing) Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Lepu Medical Technology (Beijing) Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Lepu Medical Technology (Beijing) Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Lepu Medical Technology (Beijing) Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Lepu Medical Technology (Beijing) Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Lepu Medical Technology (Beijing) Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Lepu Medical Technology (Beijing) Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Lepu Medical Technology (Beijing) Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Lepu Medical Technology (Beijing) Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Lepu Medical Technology (Beijing) Co Ltd (300003):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Macquarie Telecom Group Limited (MAQ):企業の財務・戦略的SWOT分析
    Macquarie Telecom Group Limited (MAQ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Avedro Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Avedro Inc (Averdro) is a medical device company that manufactures and distributes cross-linking systems and riboflavin ophthalmic products. The company’s products include mosaic systems for PiXL, lasik xtra, and accelerated cross-linking; KXL systems for lasik xtra and accelerated cross-lin …
  • The Chemours Company LLC:企業の戦略・SWOT・財務情報
    The Chemours Company LLC - Strategy, SWOT and Corporate Finance Report Summary The Chemours Company LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • AltaGas Ltd.:企業の戦略・SWOT・財務分析
    AltaGas Ltd. - Strategy, SWOT and Corporate Finance Report Summary AltaGas Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Siegfried Holding AG (SFZN)-製薬・医療分野:企業M&A・提携分析
    Summary Siegfried Holding AG (Siegfried) is a custom manufacturing organization (CMO). The company is active in the primary and secondary production of drugs. It develops and manufactures active pharmaceutical ingredients (APIs) for the research-based pharmaceutical industry and corresponding interm …
  • Kemwell Biopharma Pvt Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Kemwell Biopharma Pvt Ltd (Kemwell) formerly Kemwell Pvt Ltd, a subsidiary of Recipharm AB is a healthcare solutions provider that offers product development and manufacturing solutions. The organization provides contract pharmaceutical development and manufacturing organization and concentr …
  • Cytox Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Cytox Ltd (Cytox) is a diagnostic and prognostic service provider that develops services for neurodegenerative disorders. The company’s blood tests are used to predict, which patients with MCI will develop Alzheimer's disease. Its biomarkers are based on the cell cycle hypothesis of Alzheime …
  • East Japan Railway Co:戦略・SWOT・企業財務分析
    East Japan Railway Co - Strategy, SWOT and Corporate Finance Report Summary East Japan Railway Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Gujarat Sidhee Cement Ltd.:企業の戦略・SWOT・財務情報
    Gujarat Sidhee Cement Ltd. - Strategy, SWOT and Corporate Finance Report Summary Gujarat Sidhee Cement Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Sime Darby Bhd (SIME):企業の財務・戦略的SWOT分析
    Sime Darby Bhd (SIME) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Renk AG (ZAR):企業の財務・戦略的SWOT分析
    Renk AG (ZAR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Exfo Inc.:企業の戦略・SWOT・財務分析
    Exfo Inc. - Strategy, SWOT and Corporate Finance Report Summary Exfo Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Epic Sciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Epic Sciences Inc (Epic Sciences) focuses to develop novel diagnostics for personalized treatment of cancer. The company develops AR-V7 test to identify and molecularly characterize circulating tumor cells in a blood sample. It also offers biopharma solutions such as resistance to AR signali …
  • Oil-Dri Corporation of America (ODC):企業の財務・戦略的SWOT分析
    Summary Oil-Dri Corporation of America (Oil-Dri) is a manufacturer and supplier of sorbent products. The company offers granular clay absorbents, universal absorbent products, oil only absorbents, haz mat, socks and boom, spill kits, sweeping compounds, and secondary containment products. Its univer …
  • Tristan Technologies Inc:企業の製品パイプライン分析2018
    Summary Tristan Technologies Inc (Tristan) is a medical device company that offers laboratory products. The company designs, develops and manufactures components and systems for biomagnetic measurement and clinical applications. Its products comprise biomagnetic devices, geomagnetic, cryogenic, non- …
  • Neurelis Inc-製薬・医療分野:企業M&A・提携分析
    Summary Neurelis Inc. (Neurelis) is a specialty pharmaceutical company, which develops medicines to target unmet medical need in epilepsy and acute anxiety episodes. The company's product portfolio includes NRL-1 (intranasal diazepam), a proprietary formulation, for epilepsy in pediatric and adult p …
  • Sunkist Growers, Inc.:企業の戦略的SWOT分析
    Sunkist Growers, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Axalta Coating Systems Ltd.:戦略・SWOT・企業財務分析
    Axalta Coating Systems Ltd. - Strategy, SWOT and Corporate Finance Report Summary Axalta Coating Systems Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Sumitomo Heavy Industries Ltd (6302)
    Sumitomo Heavy Industries Ltd (6302) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • EllisDon Corporation:企業の戦略・SWOT・財務情報
    EllisDon Corporation - Strategy, SWOT and Corporate Finance Report Summary EllisDon Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆